HomeExThera Medical Corporation

ExThera Medical Corporation

Seraph® 100 Blood Filter Receives CE Mark

This CE Mark signifies that Seraph 100 meets the safety and performance requirements for medical devices in the European Economic Area (EEA) as an adjunct to anti-infective therapy, and it gives ExThera access to a market of 500 million people.

ExThera Medical Announces Completion of CE Mark Registration Trial Evaluating the Safety of Seraph® 100 Blood Filter

6/13/18: Trial provides foundation for submission for european CE Mark application.

ExThera Medical Announces Creation of European Subsidiary

3/19/18: Carla Kikken-Jussen Appointed as Managing Director to Oversee the Strategic Direction of ExThera Medical’s Operations in Europe.